Philip Morris
Sensory Blockade of Smoking Satisfaction
Fields
- Author
- Ertle, A.
- Lafer, R.
- Rose, J.E.
- Tashkin, D.P.
- Zinser, M.C.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Natl Inst on Drug Abuse
- Veterans Administration Medical Center
- Named Person
- Rose, J.E.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Ankho Intl
- Pharmacology Biochemistry + Behavior
- Univ of Ca
- Veterans Administration Medical Center
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
I
I
Pharmacology Biochemistry & Behavior, V o1. 23, pp. 289-293, 1985. ° Ankho International Inc.
Printed in the U.S.A. 00913057/85 $3.00 + .00
Sensory Blockade of Smoking Satisfaction1
JED E. ROSE,*tE DONALD P. TASHKIN,$ ALAN ERTLE,#
MICHAEL C. ZINSER*t AND ROBERT LAFER*t
*Department of Psychiatry and Biobehavioral Sciences, The Neuropsychiatric Institute
School of Medicine, University of California, Los Angeles, CA 90024
tVeterans Administration Medical Center West Los Angeles, Brentwood Division, Los Angeles, CA 90073
tDepartment of Medicine, Division of Pulmonary Disease, School of Medicine
University of California, Los Angeles, CA 90024
Received 21 September 1984
ROSE, J. E., D. P. TASHKIN, A. ERTLE, M. C. ZINSER AND R. LAFER. Sensory blockade of smoking
satisfaction.
PHARMACOL BIOCHEM BEHAV 23(2) 289-293, 1985.-Cigarette smokers were presented with controlled doses
of
cigarette smoke to determine whether the resulting reduction in cigarette craving depended upon
perceiving the sensory
qualities of the smoke. Cigarette craving was assessed before and after inhaling controlled doses of
smoke in two condi-
tions: (1) Local anesthesia of the upper and lower respiratory airways, induced by mouth rinsing,
gargling and inhalation of
a mist containing the topical anesthetic lidocaine; and (2) no-anesthesia control, in which all
solutions were saline. A sham
smoking procedure was presented in both conditions. Craving and ad lib smoking behavior were also
assessed 30 minutes
after controlled smoking. The results indicated that smoke, as opposed to sham puffs, significantly
reduced reports of
cigarette craving, and local anesthesia significantly blocked this immediate reduction in craving
produced by smoke
inhalation. Puffs were also rated as less desirable in the anesthesia condition. Thirty minutes
after smoking, craving was no
different in the anesthesia and saline control conditions. However, craving as well as smoking
intake in both conditions was
less when smoke had been given previously than in the sham smoking control. These results suggest
that sensory cues
accompanying inhalation of cigarette smoke are important determinants of immediate smoking
satisfaction. However, the
sustained effects of smoke ihtake on subsequent smoking behavior (30 min later) may be mediated by
processes other than
sensory stimulation of the respiratory tract, such as plasma nicotine levels.
Nicotine Cigarette smoking Satiation Anesthesia Conditioned reinforcement Chemosensory cues
~ AS smoke passes from the burning cigarette into a smoker's
mouth and past the pharynx and larynx into the lower res-
piratory tract it produces a variety of sensations. It has been
hypothesized that these chemosensory cues become potent
conditioned reinforcing stimuli due to their association with
the reinforcing actions of nicotine in the central nervous sys-
tem [1,2]. In a previous study [14], we showed that local
I anesthesia of the mouth, pharynx and lower respiratory air-
ways produced a graded reduction in reported cigarette crav-
ing. Ratings of puff desirability were also reduced by the
sensory blockade.
However, in the latter study the subjective satisfaction
obtained from smoking, as measured by the reduction in
cigarette craving after smoking, could not be clearly as-
sessed because smoking topography was not controlled.
I Th ere was a nonsignificant trend for CO level to increase less
after smoking when subjects' airways were anesthetized,
suggesting there may have been less inhalation of smoke
than in the no-anesthesia condition.
I In the present study we measured the change in cigarette
craving produced by a fixed dose of cigarette smoke both
with and without local airway anesthesia. We hoped to de-
termine whether elimination of a major portion of the local
sensory feedback would block the reduction in craving usu-
ally produced by smoking, which would test the hypothesis
that this sensory feedback is reinforcing to smokers.
METHOD
Subjects
Eight subjects (6 males, 2 females) with a mean age of
29.8 years (s'.d.=7.5) participated in the study. Subjects
smoked at least 15 cigarettes per day (mean=24.8, s.d.=7.8)
with a mean nicotine delivery (by FTC method) of 1.0 mg
(s.d.=0.19), and a mean total particulate delivery of 15.6 mg
(s.d.=3.2). All subjects except one smoked filtered ciga-
rettes, and two subjects smoked cigarettes with ventilated
filters.
These subjects had been selected in a preliminary screen-
ing session which determined the degree and duration of
numbness reported by subjects after local anesthetic admin-
istration. The aim was to include only those who showed a
comparable time course of anesthesia. In our prior study
[14], using methods of administering lidocaine similar to
those of the present study, subjective ratings of numbness in
the mouth and throat were found to correlate highly with the
'Supported by the Medical Research Service of the Veterans Administration and by Grant No. 02665
from the National Institute on Drug
Abuse.
IItequests for reprints should be addressed to Jed E. Rose, Ph.D., Veterans Administration Medical
Center West Los Angeles, Brentwood
f vision, 691/B151D, 11301 Wilshire Boulevard, Los Angeles, CA 90073.
289
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
290
following indices of anesthesia: (1) depression of taste sen-
sation, using different concentrations of sucrose, (2) reduc-
tion in the objectively stimulated gag reflex and (3) reduction
in cough elicited by serially increasing concentrations of cit-
ric acid, a standard irritant.
In the screening session prior to the present study, sub-
jects reported the degree of numbness in the mouth and
throat for 30 min after local airway anesthesia. Subjects re-
ported numbness every 5 min, using rating scales in which
"0" corresponded to "no numbness" and "10" represented
"complete numbness." Criteria for inclusion in the study
were that subjects report substantial numbness of the mouth
and throat (a rating of at least 5) for at least 5 min after
receiving the local anesthetic, and by 30 min the ratings of
numbness must have fallen to a low level (a rating less than
2). Approximately 60% of the subjects screened met these
criteria. Thus, for all subjects included in the study, the time
course of anesthesia was comparable.
Procedure
The procedures for administering the local anesthetic and
for delivering fixed doses of smoke were used in every con-
dition and will be described first.
Upper and Lower Airway Anesthesia Procedure
Subjects rinsed their mouths with 2% lidocaine for 90 sec
on each of three consecutive occasions. Mouth rinsing was
followed immediately by gargling three times with 2%
lidocaine. Following this, subjects inhaled 60 breaths (tidal
breathing) from a nebulizer that delivered a mist containing
4% lidocaine (pH of 6.3). The lidocaine aerosol was gener-
ated by adding 4 cc of 4% lidocaine solution to a flow through
nebulizer (DeVilbiss, Model 646) attached to a compressor-
driven aerosol generator (Pulmo-Aide DeVilbiss 561 series;
Somerset, PA 15501). The inhalations required approx-
imately five minutes, at the end of which subjects rated
numbness in their mouth and throat using tenpoint scales.
Controlled Smoke Delivery Method
To control total smoke intake, the number of puffs, puff
volume and inhalation volume were controlled. Before each
puff was delivered, a water-displacement spirometer was
first primed with 500 cc air. Then a 40 cc puff was drawn
from the subject's own brand of cigarette using a syringe.
The smoke was immediately emptied into a temporary stor-
age bag (in which it remained less than 5 sec before being
inhaled). Two electronically operated valves (Skinner elec-
tric valve No. V52DA1125) controlled the flow of air and
smoke into a short length of tygon tubing which was attached
to a face mask. The face mask was modified from an Ambu
resuscitator mask, and formed an airtight seal around the
subject's nose and mouth. When instructed to inhale a puff,
subjects held the mask over their nose and mouth, and
placed their lips around the tygon tubing which protruded
through the mask approximately 5 cm. At the beginning of an
inhalation, one valve opened, permitting smoke to flow into
the tygon tubing mouthpiece. Immediately after the smoke
(40 cc) was inhaled from the storage bag, a second valve
opened, allowing 500 cc air to be inhaled from the spirome-
ter. Subjects exhaled completely as soon as the air had been
drawn from the spirometer. This procedure was repeated for
each puff.
Each subject was presented with four conditions, and be-
ROSE ET AL.
cause each condition required approximately 1'/s hr, only
two conditions were given in the same day, with a 5 minute
rest in between the first and second halves of the session. To
minimize sequence effects, the order of presentation was
counterbalanced across subjects. The four conditions were
as follows:
(1) Controlled smoking with local airway anesthesia.
Controlled smoking periods were interspersed with presen-
tations of lidocaine, to maintain the anesthesia throughout
smoking satiation and also to avoid oversatiating subjects by
presenting a long uninterrupted series of puffs. Subjects re-
ceived three sets of puffs, in which the number of puffs, puff
volume and inhalation volume were controlled with the
technique described above. Each of the three smoke pre-
loads, presented every 10 min, consisted of 15 puffs, taken
from 2 successive cigarettes. The interpuff interval was 30
sec. Immediately prior to each set of puffs, subjects rinsed
their mouths, gargled and inhaled lidocaine, according to the
airway anesthesia procedure described above, except that
the "booster" anesthesia presentations immediately prior to
the second and third set of puffs required only 1 rinse, I
gargle and 40 inhalations of lidocaine.
(2) Controlled smoking without anesthesia. This condi-
tion was identical to Condition 1, except that subjects rinsed,
gargled and inhaled saline instead of lidocaine.
(3) Sham smoking with airway anesthesia. In this condi-
tion, lidocaine anesthesia was administered at the same
times and in the same manner as in Condition 1; however,
instead of receiving controlled preloads of smoke, each puff
(15 puffs per preload) was drawn with a syringe through a
plastic cigarette holder (Water Pik "One Step at a Time"
Filter No. 4) which diluted the smoke stream with smoke-
free air by approximately 95%. (We determined this by
weighing the residue trapped in Cambridge filter pads after
smoking cigarettes in a standard manner either with or with-
out the cigarette holder.) Puffs were always delivered from
behind a partition so that subjects would not observe
whether the puff to be delivered was undiluted smoke or
diluted smoke ("sham").
(4) Sham smoking without airway anesthesia. In this
condition, saline was presented instead of lidocaine, and
sham puffs were given instead of smoke.
Thus, in each of these four conditions, three puffing
periods (smoke or sham) alternated with three anesthesia (or
saline) presentations. Subjects reported their cigarette crav-
ing using a tenpoint scale before and after each set of puffs.
Carbon monoxide concentrations were measured before and
after each series of puffs using an electrochemical analyzer
(Ecolyzer, Model A). Each sample was collected after 20 sec
breath holding and exhalation of the first 500 cc of expirate to
eliminate dead space air from the sample.
A thirty-minute period followed, in which no smoking
was permitted, during which any numbness induced by pre-
vious anesthesia dissipated. Subjects then reported their
cigarette craving and were allowed to smoke freely for 15
minutes (ad lib test), using their customary brand of ciga-
rette. The purpose of this test was to assess the sustained
effects of prior smoke or sham inhalations on cigarette crav-
ing and smoking behavior. Subjects smoked each cigarettCZ
through a cigarette holder containing a self-heated thermistop
sensor which reacted to changes in smoke flow [5]. FIoWo,~,
signals were integrated to provide an estimate of cumulattvr=
puff volume inhaled and also to provide an estimate of the
number of puffs. The change in endexpired carbon monoxide~
concentrations after ad lib smoking was also measured. C'
~
~
~

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
STc13SORY BLOCKADE OF SMOKING SATISFACTION
RBSLTI TS
Reliability of Puff Delivery System
Controlled smoke doses. Each set of controlled puffs in-
creased endexpired air carbon monoxide concentrations by a
uniform amount (approximately 12 ppm), which did not dif-
fer between anesthesia and control conditions.
(Anesthesia x Puffing Period analysis of variance for the
smoking-condition only: F(1,7)=0.00, p>0.9). These results
indicate that the puff delivery system prevented compensa-
tory changes in smoking topography that might have other-
wise caused variations in the amount of smoke inhaled.
Subjective reports of cigarette craving were significantly
reduced after each preload of smoke as opposed to sham
smoke (a mean change in craving of -2.8 after smoke vs. 0
after sham (Smoke x Puffing Period analysis of variance for
no-anesthesia conditions; F(1,7)=38.97, p<0.001). Puffs of
smoke were also rated as significantly more desirable than
sham puffs (4.6 vs. 0.7 in the no-anesthesia conditions
(Smoke x Puffing Period analysis of variance: F(1,7) = 18.02,
p<0.01). Controled puffs of smoke were only somewhat less
desirable than puffs taken freely through a cigarette holder
during the ad lib test: the mean rating across the three smoke
periods was 4.6 (in the no-anesthesia, real smoke condition)
vs. 6.5 during the ad lib test, paired t(7)=2.3, p>0.05.
Hence, we conclude that although smoke was delivered in a
highly stereotyped and artificial manner, it was nonetheless
subjectively satisfying.
Effectiveness of Anesthesia
The extent and duration of anesthesia were assessed by
subjective ratings of numbness in the mouth and throat.
Ratings of numbness after saline rinses, gargles and inhala-
tions were always near zero. Immediately after the first ad-
ministration of lidocaine, ratings of numbness in the mouth
and throat were 8.8± 1.01, and 8.7-* 1.29, respectively. Thus,
while some ability to perceive the local chemosensory stimu-
lation of smoke no doubt remained, these sensations were
substantially blunted.
Effects of Sensory Blockade on Cigarette Craving and
Smoking Satisfaction
To analyze the effects of airway anesthesia on the subjec-
tive satisfaction produced by the fixed preloads of smoke,
craving before and after smoking was compared between
anesthesia and saline control conditions. Mean craving in the
real smoke conditions, before the first smoke delivery, was
lower in the anesthesia condition than in the no anesthesia
condition (2.4 vs. 3.8, paired t(7)=3.25, p<0.05), replicating
the finding in our previous study [ 14]. The mean reduction in
craving after each set of controlled puffs of smoke was signif-
icantly less in the anesthesia condition than in the saline
control condition (a mean reduction of 1.1 vs. 2.7,
AnesthesiaxPuffmg Period analysis of variance:
F(1,7)=18.18, p<0.01), suggesting that smoking satisfaction
was partially blocked by lidocaine anesthesia (see Fig. 1).
This reduction in the effects of smoke on craving in the
anesthesia condition was not simply the result of a lower
pre-smoking level of craving in the anesthesia condition. An
analysis of covariance on post-smoking craving, partialling
out pre-smoking craving showed a significant main effect of
anesthesia, F(1,6)=11.74, p<0.02. Desirability ratings of
puffs of smoke were also reduced by the anesthesia,
291
5-1
I
\-,,,_ANESTHESIA
\
\b
SALINE
7
SMOKING SMOKING
FIG. 1. Mean reported cigarette craving before and after smoking in
two conditions: upper and lower airway anesthesia vs. saline con-
trol.
F(1,7)=6.16, p<0.05. Mean desirabilityy was 3.1 in the
anesthesia condition and 4.6 in the no anesthesia condition.
Effects of Local Airway Anesthesia on Ratings of Strength
and Harshness
There were no significant effects of anesthesia upon puff
strength and harshness ratings. This nonintuitive finding was
also reported in the Rose et al. (1984) study [14]. Smoke was,
of course, rated much stronger and harsher than the sham
inhalations of diluted smoke (Smoke xAnesthesiax Puffing
Period analyses of variance showed a main effect of smoke
on strength and harshness: mean strength was 5.6 (smoke)
vs. 0.9 (sham), F(1,7)=29.95, p<0.001; mean harshness was
5.4 (smoke) vs. 0.7 (sham), F(1,7)=44.61, p<0.001).
Ad Lib Smoking Period
The ad hb test smoking period occurred at least 30 min-
utes after the last set of controlled puffs, and long enough
after previous lidocaine administration for the subjective
numbness to have disappeared. After the prior controlled
puffs of smoke, craving had been higher in the anesthesia
condition than in the saline control condition, yet im-
mediately before the ad lib test smoking period there was no
difference in craving (Smoke x Anesthesia analysis of vari-
ance: F(1,7)=0.5, p>0.8). However, the same analysis
showed that craving before the ad Gb test smoking period
was significantly lower in the smoke conditions than in the
sham smoke conditions (4.9 after smoke vs. 6.2 after sham;
F(1,7)=24.20, p<0.01). SmokexAnesthesia analyses of
variance for each of the three behavioral measures of smok-
ing during the ad lib smoking period (number of puffs, puff
volume, and increase in endexpired CO) showed a reduced
voluntary smoke intake after controlled smoke deliveries
relative to sham puffing conditions: 14.4 vs. 19.6 for mean
number of puffs, F(1,7)=3.72, p<0.1; 687 cc vs. 926 cc for
puff volume, F(1,7)=3.89, p<0.1, and 7.2 ppm vs. 11.2 ppm
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
292
for endexpired CO increase, F(1,7)=12.53, p<0.01. Thus,
two measures of smoking motivation (cigarette craving and
CO intake from ad lib smoking) were significantly reduced
by prior smoke preloads, and the remaining two indices
(number of puffs and cumulative puff volume) showed trends
in the same direction.
While prior controlled deliveries of smoke influenced
smoking during the ad lib test, prior anesthesia did not; a
Smoke x Anesthesia analysis of variance for each of the
smoking measures during the ad lib test showed no differ-
ence between anesthesia and saline control conditions,
F(1,7)=0.05; F(1,7)=0.99, F(1,7)=0.58, F(1,7)=1.53 for
craving, CO increase, number of puffs, and puff volume,
respectively.
DISCUSSION
The main fmding of this study was that smoking satisfac-
tion, as measured by the immediate reduction in cigarette
craving after inhalation of controlled amounts of smoke, was
substantially blocked by local anesthesia of the respiratory
airways. These results add to our previous fmdings [14] im-
plicating the chemosensory feedback from smoke inhalation
as reinforcing stimuli. Whether these cues are conditioned or
unconditioned determinants of cigarette craving can be an-
swered only by further research.
The counterintuitive finding that anesthesia did not affect
ratings of strength and harshness of cigarette smoke has been
addressed previously [14]. One explanation considered was
that subjects altered puffing topography to compensate for
the effects ofiocal anesthesia; this possibility is ruled out by
the present study, in which smoking topography was con-
trolled. It is likely that incomplete anesthesia of the lower
respiratory tract, where harshness and strength may have
been perceived, accounts for the absence of a significant
influence of anesthesia on strength and harshness ratings.
The greater surface area present in the lower respiratory
passages may require more anesthetic and/or smaller aerosol
droplets than the upper airways to be fully numbed. Also,
more effective anesthesia might be necessary to block the
irritant properties of smoke than to block other sensory mo-
dalities. These irritant effects result from nicotine and gas
phase constituents in smoke [4,11]. Those areas or con-
stituents not blocked by the dose of lidocaine used in our
study may be adequate for discrimination of strength and
harshness, but they are not sufficient to mediate subjective
satisfaction.
The results also showed that craving and smoking behav-
ior during the ad lib smoking test period, after the local anes-
thetic had largely worn off, were no different between
anesthesia and control conditions. Nonetheless, craving and
smoking behavior were lower in both conditions if smoke
had been given 30 min prior to ad lib smoking (versus sham
control). This suggests that there may be an important dis-
tinction between the immediate satiating effects of cigarette
ROSE ET AL.
smoke, which were partially blocked by airway anesthesia,
and the sustained effects, which were unaffected by prior
anesthesia at the time smoke had been given. Conceivably,
the immediate satiation following smoking may be mediated
to a significant extent by sensory feedback from the respira-
tory tract, while sustained effects might be due to other ef-
fects, such as elevated plasma nicotine levels. If this specu-
lation is borne out, cigarette smoking could be viewed as
being analogous to other consummatory behaviors. For
example, drinking is initiated by water deprivation which is
sensed in the central nervous system and gives rise to a
craving for liquids (thirst). Ingestion of liquids stimulates
afferent sensory fibers causing immediate satiation well be-
fore the physiological deficit which generated the craving has
been reversed [3]. Stimulation of respiratory sensations by
cigarette smoke may be analogous to peripheral feedback
following drinking, and the central nervous system effects of
smoking or nicotine may be analogous to the reversal of
water depletion following drinking (except that nicotine's
central nervous sytem effects occur much sooner after inha-
lation compared to those of water after drinking).
Our interpretation of the present results predicts that
methods of administering nicotine without the specific sen-
sory qualities of smoke would not be perceived as com-
pletely satisfying, even though they may partially reduce
craving for a cigarette. For example, nicotine chewing gum
has been shown to reduce cigarette craving [7,12] but it has
undesirable sensory qualities (e.g., bad taste) that do not
resemble cigarette smoke. This may account for its low
addiction liability (12). We predict that transdermal nicotine
administration [13] would similarly depress cigarette craving
without being perceived as an enjoyable substitute for smok-
ing, due to its lack of sensory effects. Nor are intravenous
injections of nicotine a complete substitute for cigarettes (6,
8, 10]. Russell and Feyerabend [15] have argued that the
rapidity of nicotine absorption from the pulmonary route is
important in producing the reinforcing effects of cigarette
smoke. However, even large doses of nicotine administered
over extremely short periods of time (e.g., 3 mg in 10 sec) do
not fully duplicate these reinforcing effects [6]. The view that
inhalation of nicotine "boli" is responsible for the uniquely
desirable qualities of cigarettes to a smoker has been widely
accepted despite the absence of direct experimental support
[9]. The results of our present study support an alternative
account for the enjoyment and satisfaction reported by ciga-
rette smokers, i.e., the conditioned reinforcing effects of the
sensory feedback accompanying inhalation. When these
cues were partially blocked (with local anesthesia) the satis-
faction of smoking was blunted, despite the fact that equiv-
alent boli of nicotine had been inhaled. It is conceivable that
the conditioning of smoking-related cues might be facilitated
by the temporal contiguity afforded by the short lung-to-
brain transit time for inhaled nicotine. Whether a rapid
nicotine absorption is required to effectively condition sen-
sory cues is an issue that should be addressed in future re-
search.
REFERENCES
1. Ashton, H. and R. Stepney. Smoking Psychology and Phar-
macology. London: Tavistock, 1982.
2. Cain, W. S. Sensory attributes to cigarette smoking. In: Ban-
bury Report 3: A Safe Cigarette?, edited by G. B. Gori and
F. G. Bock. New York: Cold Spring Harbor Laboratory, 1980.
3. Deutsch, J. A. and D. Deutsch. Physiological Psychology.
Homewood, IL: Dorsey, 1973.
4. Driscoll, P., A. Deuber, K. Baettig and E. Grandjean. Effect of
filtered smoke on rats. Nature 237: 37-38, 1972.
2C464oo19'7

I
I
I
I
I
I
I
I
I
I
I
I
I
I
rSENSORY BLOCKADE OF SMOKING SATISFACTION
5, Gritz, E. R., J. E. Rose and M. E. Jarvik. Regulation of to-
bacco smoke intake with paced cigarette presentation. Phar-
macol Biochem Behav 18: 457-462, 1983.
6. Henningfield, J. E., K. Miyasato and D. R. Jasinski. Cigarette
smokers self-administer intravenous nicotine. Pharmacol
Biochem Behav 19: 887-890, 1983.
7. Jarvis, M. J., M. Raw, M. A. H. Russell and C. Feyerabend.
Randomized controlled trial of nicotine chewing gum. Br Med J
285: 537-540, 1982.
B. Jones, R. T., T. R. Farrell, III and R. I. Herning. Tobacco
smoking and nicotine tolerance. In: NIDA Research Mono-
graph 20, Self-Administration of Abused Substances, edited by
N. A. Krasnegor. United States Public Health Service, De-
partment of Health, Education, and Welfare, National Institute
on Drug Abuse. Rockville: Division of Research, 1978, pp.
202-208.
9. Kozlowski, L. T. The determinants of tobacco use: cigarette
smoking in the context of other forms of tobacco use. Can J
Public Health 73: 236-241, 1982.
293
10. Kumar, R. Tobacco smoking: tests of the nicotine dependence
hypothesis. In: Electrophysiological Effects of Nicotine, edited
by A. Remond and C. Izard. Amsterdam: Elsevier/North Hol-
land Biomedical Press, 1979, pp. 245-254.
11. Lundberg, J. M., C. R. Martling, A. Saria, K. Folkers and S.
Rosell. Cigarette smoke-induced airway oedema due to activa-
tion of capsaicin-sensitive vagal afferents and substance P re-
lease. Neuroscience 10: 1361-1368, 1983.
12. Raw, M., M. J. Jarvis, C. Feyerabend and M. A. H. Russell
Comparison of nicotine chewing-gum and psychological treat-
ments for dependent smokers. Br Med J 281: 481-482, 1980.
13. Rose, J. E., M. E. Jarvik and K. D. Rose. Transdetmal adminis-
tration of nicotine. Drug Alcohol Depend 13: 209-213, 1984.
14. Rose, J. E., M. D. Zinser, D. P. Tashkin, R. Newcomb and A.
Ertle. 8ubjective response to cigarette smoking following air-
way anesthetization. Addict Behav 9: 211-215, 1984.
15. Russell, M. A. H. and C. Feyerabend. Cigarette smoking: a
dependence on high-nicotine boli. Drug Metab Rev 8: 29-57,
1978.
I
